ISB News

Aitchison Lab Accepts ALS Ice Bucket Challenge

Jennifer Smith, senior research scientist in the John Aitchison Lab, was tagged to do the ALS Ice Bucket Challenge. And because the Aitchison group studies ALS, Jennifer’s lab mates took the challenge, too. Jennifer offered this description of the work they are doing to create a blood test for early detection of ALS:

ISB is developing a multi-component blood-based assay (blood test) for early detection and disease tracking of ALS. We are doing this because there are no good diagnostic tests for ALS and, on average, it takes a year to get a definitive diagnosis, resulting in significant loss of therapeutic opportunity. There is a dire need for a robust and quantitative blood biomarker assay to help confirm initial diagnosis of ALS and to track disease activity not only for clinical use, but to also to develop new therapies for the disease.

The assay we are developing is called the indicator cell assay platform (iCAP) for blood-based diagnostics that can be used for early detection of ALS, and as a diagnostic tool for drug development. The iCAP uses cultured cells as biosensors, capitalizing on the natural ability of cells to detect signals present in serum from patients with ALS with exquisite sensitivity, as opposed to traditional assays that rely on direct detection of molecules in blood.

You can support ALSA.org to raise awareness about ALS. Or you can support ALS research directly with a gift to Institute for Systems Biology. Support ALS research directly.

You Have 24 Hours to Accept the Challenge!

And now, the Aitchison Lab challenges the following groups:

  • Mike Rout Lab, The Rockefeller University
  • Alan Aderem Lab, Seattle BioMed
  • Dave Goodlett Lab, University of Maryland

Learn more about the Aitchison Lab and Jennifer Smith. Jennifer received a “proof of concept” grant from the Life Sciences Discovery Fund to develop a similar early detection test for Alzheimer’s.

Ice Bucket Challenge Photo Gallery

You may also visit the full gallery on Flickr.

ALS5614 ALS5615 ALS5616

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.